Penbrook Management LLC
- SEC CIK
- 0001381055
- Latest filing
- Jul 23, 2026
IMDX holding history
Insight Molecular Diagnostics Inc. in every 13F filed by Penbrook Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IMDX overviewAll 13F holders of IMDXFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −207,675−100.0% | Sold out | Holders |
| Q1 2023 | 207,675 | $73.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 207,675 | $66.6K | 0.1% | −355,675−63.1% | Reduced | Holders |
| Q3 2022 | 563,350 | $411.0K | 0.4% | −12,400−2.2% | Reduced | Holders |
| Q2 2022 | 575,750 | $518.0K | 0.4% | −2,400−0.4% | Reduced | Holders |
| Q1 2022 | 578,150 | $861.0K | 0.6% | 00.0% | Unchanged | Holders |
| Q4 2021 | 578,150 | $1.25M | 0.8% | +950+0.2% | Added | Holders |
| Q3 2021 | 577,200 | $2.06M | 1.3% | +155,425+36.9% | Added | Holders |
| Q2 2021 | 421,775 | $2.42M | 1.5% | −2,000−0.5% | Reduced | Holders |
| Q1 2021 | 423,775 | $2.20M | 1.6% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.